Influence of C-terminal α-helix hydrophobicity and aromatic amino acid content on apolipoprotein A-I functionality

Lund-Katz, 2010, High density lipoprotein structure–function and role in reverse cholesterol transport, Subcell. Biochem., 51, 183, 10.1007/978-90-481-8622-8_7

Rothblat, 2010, High-density lipoprotein heterogeneity and function in reverse cholesterol transport, Curr. Opin. Lipidol., 21, 229, 10.1097/MOL.0b013e328338472d

Oram, 2005, ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease, Physiol. Rev., 85, 1343, 10.1152/physrev.00005.2005

Francis, 1995, Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease, J. Clin. Invest., 96, 78, 10.1172/JCI118082

Oram, 2000, Tangier disease and ABCA1, Biochim. Biophys. Acta, 1529, 321, 10.1016/S1388-1981(00)00157-8

Lawn, 1999, The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway, J. Clin. Invest., 104, R25, 10.1172/JCI8119

Oram, 2000, ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages, J. Biol. Chem., 275, 34508, 10.1074/jbc.M006738200

Lin, 2000, Apolipoprotein binding to protruding membrane domains during removal of excess cellular cholesterol, Atherosclerosis, 149, 359, 10.1016/S0021-9150(99)00503-1

Vaughan, 2003, ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions, J. Lipid Res., 44, 1373, 10.1194/jlr.M300078-JLR200

Tang, 2009, The cell cholesterol exporter ABCA1 as a protector from cardiovascular disease and diabetes, Biochim. Biophys. Acta, 1791, 563, 10.1016/j.bbalip.2009.03.011

Shao, 2010, Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export, J. Lipid Res., 51, 1849, 10.1194/jlr.M004085

Vedhachalam, 2007, Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles, J. Biol. Chem., 282, 25123, 10.1074/jbc.M704590200

Gillotte, 1999, Apolipoprotein-mediated plasma membrane microsolubilization, J. Biol. Chem., 274, 2021, 10.1074/jbc.274.4.2021

Duong, 2006, Characterization of nascent HDL particles and microparticles formed by ABCA1-mediated efflux of cellular lipids to apoA-I, J. Lipid Res., 47, 832, 10.1194/jlr.M500531-JLR200

Saito, 2004, Contributions of domain structure and lipid interaction to the functionality of exchangeable human apolipoproteins, Prog. Lipid Res., 43, 350, 10.1016/j.plipres.2004.05.002

Sviridov, 1996, Efflux of cellular cholesterol and phospholipid to apolipoprotein A-I mutants, J. Biol. Chem., 271, 33277, 10.1074/jbc.271.52.33277

Burgess, 1999, Deletion of the C-terminal domain of apolipoprotein A-I impairs cell surface binding and lipid efflux in macrophage, Biochemistry, 38, 14524, 10.1021/bi990930z

Panagotopulos, 2002, The role of apolipoprotein A-I helix 10 in apolipoprotein-mediated cholesterol efflux via the ATP-binding cassette transporter ABCA1, J. Biol. Chem., 277, 39477, 10.1074/jbc.M207005200

Favari, 2002, The C-terminal domain of apolipoprotein A-I is involved in ABCA1-driven phospholipid and cholesterol efflux, Biochem. Biophys. Res. Commun., 299, 801, 10.1016/S0006-291X(02)02745-6

Chroni, 2003, The central helices of apoA-I can promote ATP-binding cassette transporter AI (ABCA1)-mediated lipid efflux, J. Biol. Chem., 278, 6719, 10.1074/jbc.M205232200

Vedhachalam, 2004, Influence of apo A-I structure on the ABCA1-mediated efflux of cellular lipids, J. Biol. Chem., 279, 49931, 10.1074/jbc.M406924200

Tanaka, 2008, Influence of tertiary structure domain properties on the functionality of apolipoprotein A-I, Biochemistry, 47, 2172, 10.1021/bi702332b

Brouillette, 2001, Structural models of human apolipoprotein A-I: a critical analysis and review, Biochim. Biophys. Acta, 1531, 4, 10.1016/S1388-1981(01)00081-6

Vedhachalam, 2010, Influence of apolipoprotein (Apo) A-I structure on nascent high density lipoprotein (HDL) particle size distribution, J. Biol. Chem., 285, 31965, 10.1074/jbc.M110.126292

Rubin, 1991, Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses, Proc. Natl. Acad. Sci. U. S. A., 88, 434, 10.1073/pnas.88.2.434

Reschly, 2002, Apolipoprotein A-I alpha-helices 7 and 8 modulate high density lipoprotein subclass distribution, J. Biol. Chem., 277, 9645, 10.1074/jbc.M107883200

Carnemolla, 2008, The specific amino acid sequence between helices 7 and 8 influences the binding specificity of human apolipoprotein A-I for high density lipoprotein (HDL) subclasses: a potential for HDL preferential generation, J. Biol. Chem., 283, 15779, 10.1074/jbc.M710244200

Wang, 1996, Conformations of human apolipoprotein E (263–286) and E (267–289) in aqueous solutions of sodium dodecyl sulfate by CD and 1H NMR, Biochemistry, 35, 10358, 10.1021/bi960934t

Datta, 2001, Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide, J. Lipid Res., 42, 1096, 10.1016/S0022-2275(20)31599-6

Datta, 2004, Aromatic residue position on the nonpolar face of class A amphipathic helical peptides determines biological activity, J. Biol. Chem., 279, 26509, 10.1074/jbc.M314276200

James, 2009, Aromatic residues in the C-terminal helix of human apoC-I mediate phospholipid interactions and particle morphology, J Lipid Res, 50, 1384, 10.1194/jlr.M800529-JLR200

Handattu, 2007, ApoA-I mimetic peptides with differing ability to inhibit atherosclerosis also exhibit differences in their interactions with membrane bilayers, J. Biol. Chem., 282, 1980, 10.1074/jbc.M606231200

Saito, 2003, Domain structure and lipid interaction in human apolipoproteins A-I and E: a general model, J. Biol. Chem., 278, 23227, 10.1074/jbc.M303365200

Morrow, 1999, Functional characterization of apolipoprotein E isoforms overexpressed in Escherichia coli, Protein Expr. Purif., 16, 224, 10.1006/prep.1999.1069

Markwell, 1978, A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples, Anal. Biochem., 87, 206, 10.1016/0003-2697(78)90586-9

Tanaka, 2006, Contributions of the N- and C-terminal helical segments to the lipid-free structure and lipid interaction of apolipoprotein A-I, Biochemistry, 45, 10351, 10.1021/bi060726t

Alexander, 2009, Structural and functional consequences of the Milano mutation (R173C) in human apolipoprotein A-I, J Lipid Res, 50, 1409, 10.1194/jlr.M800578-JLR200

Acharya, 2002, Comparison of the stabilities and unfolding pathways of human apolipoprotein E isoforms by differential scanning calorimetry and circular dichroism, Biochim. Biophys. Acta, 1584, 9, 10.1016/S1388-1981(02)00263-9

Segall, 2002, Influence of apoE domain structure and polymorphism on the kinetics of phospholipid vesicle solubilization, J. Lipid Res., 43, 1688, 10.1194/jlr.M200157-JLR200

Massey, 2008, Cholesterol is a determinant of the structures of discoidal high density lipoproteins formed by the solubilization of phospholipid membranes by apolipoprotein A-I, Biochim. Biophys. Acta, 1781, 245, 10.1016/j.bbalip.2008.03.003

Oram, 2001, ATP-binding cassette transporter A1 mediates cellular secretion of alpha-tocopherol, J. Biol. Chem., 276, 39898, 10.1074/jbc.M106984200

Koyama, 2009, Interaction between the N- and C-terminal domains modulates the stability and lipid binding of apolipoprotein A-I, Biochemistry, 48, 2529, 10.1021/bi802317v

Tanaka, 2011, Influence of N-terminal helix bundle stability on the lipid-binding properties of human apolipoprotein A-I, Biochim Biophys Acta, 1811, 25, 10.1016/j.bbalip.2010.10.003

Pownall, 1987, Lipid-protein interactions and lipoprotein reassembly, 95

Jonas, 1992, Lipid-binding properties of apolipoproteins, 217

Duffy, 2009, Update on strategies to increase HDL quantity and function, Nat. Rev. Cardiol., 6, 455, 10.1038/nrcardio.2009.94

Liu, 2003, Effects of apolipoprotein A-I on ATP-binding cassette transporter A1-mediated efflux of macrophage phospholipid and cholesterol, J. Biol. Chem., 278, 42976, 10.1074/jbc.M308420200

Denis, 2004, Molecular and cellular physiology of apolipoprotein A-I lipidation by the ATP-binding cassette transporter A1 (ABCA1), J. Biol. Chem., 279, 7384, 10.1074/jbc.M306963200

Krimbou, 2005, Biogenesis and speciation of nascent apoA-I-containing particles in various cell lines, J. Lipid Res., 46, 1668, 10.1194/jlr.M500038-JLR200

Mulya, 2007, Minimal lipidation of pre-beta HDL by ABCA1 results in reduced ability to interact with ABCA1, Arterioscler. Thromb. Vasc. Biol., 27, 1828, 10.1161/ATVBAHA.107.142455

Monera, 1994, Protein denaturation with guanidine hydrochloride or urea provides a different estimate of stability depending on the contributions of electrostatic interactions, Protein Sci., 3, 1984, 10.1002/pro.5560031110

Alexander, 2011, Influence of apolipoprotein A-I domain structure on macrophage reverse cholesterol transport in mice, Arterioscler. Thromb. Vasc. Biol., 31, 320, 10.1161/ATVBAHA.110.216226

Palgunachari, 1996, Only the two end helixes of eight tandem amphipathic helical domains of human apo A-I have significant lipid affinity, Arterioscler. Thromb. Vasc. Biol., 16, 328, 10.1161/01.ATV.16.2.328

Jones, 1992, Computer programs to identify and classify amphipathic alpha helical domains, J. Lipid Res., 33, 287, 10.1016/S0022-2275(20)41549-4